Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease

Pediatric Research

Volumn 75, Issue 3, 2014, Pages 453-458

  Ding, Yue Yue ^a   Ren, Yan ^a   Feng, Xing ^a   Xu, Qiu Qin ^a   Sun, Ling ^a   Zhang, Jian Min ^a   Dou, Ji Juan ^a   Lv, Hai Tao ^a   Yan, Wen Hua ^a  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD62E ANTIGEN; ENDOGLIN; GLYCOPROTEIN IB ALPHA; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ARTERY LESION; ARTICLE; BRACHIAL ARTERY; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY LESION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; FEMALE; FEVER; FLOW CYTOMETRY; FLOW MEDIATED DILATION; HEART LEFT VENTRICLE FAILURE; HUMAN; INFANT; LOW DRUG DOSE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; VASODILATATION;

BIOLOGICAL MARKERS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CHILD; CHILD, PRESCHOOL; CHINA; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY; VASODILATION;

EID: 84896888964     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.240     Document Type: Article

References (29)

1. Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol 2009;54:1911-20.
2. Ma XJ, Yu CY, Huang M, Chen SB, Huang MR, Huang GY; Shanghai Kawasaki Research Group. Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J 2010;123:2629-34.
3. Orenstein JM, Shulman ST, Fox LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE 2012;7:e38998.
4. Mitani Y. Coronary endothelial dysfunction after Kawasaki disease. J Am Coll Cardiol 2000;35:821-3.
5. Fukazawa R. Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Curr Opin Pediatr 2010;22:587-92.
6. Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 2005;26:782-6.
7. Urbina EM, Williams RV, Alpert BS, et al.; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009;54:919-50.
8. Guiducci S, Ricci L, Romano E, et al. Microparticles and Kawasaki disease: a marker of vascular damage? Clin Exp Rheumatol 2011;29: Suppl 64: S121-5.
9. Tan Z, Yuan Y, Chen S, Chen Y, Chen TX. Elevated plasma endothelial microparticles together with TNF-alpha and IL-6 in Kawasaki Disease. Indian Pediatr 2013;50:501-3.
10. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
11. Santos-García D, Rodríguez-Yáñez M, Arias-Rivas S, Blanco M. [Brachial arterial flow mediated dilation: utility in clinical and experimental practice]. Rev Neurol 2011;53:351-60.
12. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27-33.
13. Biasucci LM, Porto I, Di Vito L, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J 2012;76:2174-82.
14. Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-75.
15. Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 2010;208:264-9.
16. Parker B, Al-Husain A, Pemberton P, et al. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis 2013; e-pub ahead of print 5 May 2013.
17. Bulut D, Tüns H, Mügge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 2009;39:17-22.
18. Lackner P, Dietmann A, Beer R, et al. Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 2010;41:2353-7.
19. Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis 2010;3:173-81.
20. Clarke LA, Hong Y, Eleftheriou D, et al. Endothelial injury and repair in systemic vasculitis of the young. Arthritis Rheum 2010;62:1770-80.
21. Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr 2008;167:189-96.
22. Onouchi Y. Molecular genetics of Kawasaki disease. Pediatr Res 2009;65(5 Pt 2):46R-54R.
23. Amabile N, Guérin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-8.
24. Bulut D, Maier K, Bulut-Streich N, Börgel J, Hanefeld C, Mügge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 2008;14:336-40.
25. Esposito K, Ciotola M, Schisano B, et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 2006;91:3676-9.
26. Ayusawa M, Sonobe T, Uemura S, et al.; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4.
27. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986;7:3-9.
28. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12.
29. Newburger JW, Takahashi M, Gerber MA, et al.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.